KLC1 Deficiency Alters APP and Tau Levels and Impairs Neuronal Development

Total Page:16

File Type:pdf, Size:1020Kb

KLC1 Deficiency Alters APP and Tau Levels and Impairs Neuronal Development UNIVERSITY OF CALIFORNIA, SAN DIEGO KLC1 deficiency alters APP and tau levels and impairs neuronal development A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Rhiannon Lynn Killian Committee in charge: Professor Lawrence S. B. Goldstein, Chair Professor Don W. Cleveland Professor Marilyn G. Farquhar Professor Edward H. Koo Professor Jean Y. J. Wang 2011 The Dissertation of Rhiannon Lynn Killian is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2011 iii DEDICATION As the culmination of six years of unceasing effort, I can do no other but dedicate this work to my children, Patrick, Killian and Conley, who I hope will one day understand why I was in the laboratory when they awoke and ‘too busy’ when at home. iv EPIGRAPH It is a popular delusion that the scientific enquirer is under an obligation not to go beyond generalization of observed facts...but anyone who is practically acquainted with scientific work is aware that those who refuse to go beyond the facts, rarely get as far. Thomas Henry Huxley (1825-95) English biologist We are in the ordinary position of scientists of having to be content with piecemeal improvements: we can make several things clearer, but we cannot make anything clear. Frank Plumpton Ramsey (1903-1930) English mathematician For a successful technology, reality must take precedence over public relations, for Nature cannot be fooled. Richard Feynman (1918-1988) American physicist v TABLE OF CONTENTS DEDICATION .............................................................................................................. iv EPIGRAPH ..................................................................................................................... v TABLE OF CONTENTS .............................................................................................. vi LIST OF FIGURES ..................................................................................................... viii ACKNOWLEDGEMENTS .......................................................................................... ix VITA ............................................................................................................................... x ABSTRACT OF THE DISSERTATION ...................................................................... xi CHAPTER 1 ................................................................................................................... 1 Introduction .................................................................................................................... 1 Kinesin-1 structure and function ............................................................................ 1 Alzheimer’s Disease (AD) and axonal transport defects ....................................... 4 Modeling aspects of AD in mouse and man ........................................................... 7 References ................................................................................................................ 12 CHAPTER 2 ................................................................................................................. 19 Kinesin-1C and KLC1 affect neuronal development and APP levels in murine hippocampal neurons .................................................................................................... 19 Abstract ..................................................................................................................... 19 Introduction .............................................................................................................. 21 Materials and Methods ............................................................................................. 23 Preparation of primary mouse hippocampal cultures ........................................... 23 Analysis of hippocampal axons ............................................................................ 23 Immunofluorescence characterization of primary mouse hippocampal cultures . 24 Western blot analysis of protein levels. ................................................................ 25 Quantification of A β/P3 ....................................................................................... 26 Results and Discussion ............................................................................................. 27 Murine KLC1 and Kinesin-1C protein levels in primary hippocampal cultures are related ................................................................................................................... 27 Kinesin-1C and KLC1 may function in hippocampal neuron development ........ 29 Tau levels are unchanged in primary hippocampal neurons with reduced KLC1. .............................................................................................................................. 30 Altered extracellular A β/p3 levels in Kinesin-1C-/- hippocampal cultures ......... 32 Characterization of KLC1-/- and Kinesin-1C-/- hippocampal primary cultures .. 34 Conclusions .............................................................................................................. 35 References ................................................................................................................ 44 CHAPTER 3 ................................................................................................................. 48 Kinesin light chain 1 reduction impairs human embryonic stem cell neural differentiation and amyloid precursor protein metabolism .......................................... 48 Abstract ..................................................................................................................... 48 Introduction .............................................................................................................. 49 Materials and Methods ............................................................................................. 51 vi Cell culture and subcloning of undifferentiated Hues9 hESC lines ..................... 51 Flow cytometry ..................................................................................................... 52 Western blot analysis of protein levels ................................................................. 53 Immunofluorescence ............................................................................................ 54 Neural differentiation of hESC ............................................................................. 55 Brightfield imaging of cultures ............................................................................ 56 Neural precursor culture, viral transduction and differentiation .......................... 56 Aβ and soluble APP (sAPP) quantification .......................................................... 57 Results ...................................................................................................................... 57 KLC1 reduction does not alter hESC morphology or pluripotency ..................... 57 KLC1 depleted hESC produce cultures containing neural precursors (NPs) ....... 58 Neural precursors with reduced KLC1 do not proliferate normally ..................... 60 KLC1-deficient human neural cells exhibit reduced levels of microtubule related proteins ................................................................................................................. 61 Reduced KLC1 alters APP metabolism in human neural cultures derived from hESC ..................................................................................................................... 65 Discussion ................................................................................................................. 66 A role for the KLC1 subunit of Kinesin-1 in NP maintenance? .......................... 66 KLC1 depletion affects microtubule associated proteins ..................................... 68 Effect of KLC1 reduction on APP metabolism in human neural cultures. .......... 69 Summary ................................................................................................................... 71 Acknowledgements .................................................................................................. 71 References ................................................................................................................ 89 CHAPTER 4 ................................................................................................................. 94 Discussion ..................................................................................................................... 94 Co-regulation of KLC1 and Kinesin-1C protein levels ........................................ 94 Roles for KLC1 (and Kinesin-1C) in neural development ................................... 96 Tau and Kinesin-1 subunits KLC1 and Kinesin-1C ........................................... 102 Does Kinesin-1C regulate APP levels and metabolism by controlling APP transport? ............................................................................................................ 105 Model for KLC1 functions in neural development and in regulating neuronal Tau and A β levels. ..................................................................................................... 111 Prospects for human pluripotent stem cell based systems for modeling human development, biology and disease .....................................................................
Recommended publications
  • Hares, K. M., Miners, S., Scolding, N
    Hares, K. M. , Miners, S., Scolding, N., Love, S., & Wilkins, A. (2019). KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences. AMRC Open Research, 1, [1]. https://doi.org/10.12688/amrcopenres.12861.1 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.12688/amrcopenres.12861.1 Link to publication record in Explore Bristol Research PDF-document This is the final published version of the article (version of record). It first appeared online via F1000 Research at https://amrcopenresearch.org/articles/1-1/v1 . Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ AMRC Open Research AMRC Open Research 2019, 1:1 Last updated: 11 APR 2019 RESEARCH ARTICLE KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences [version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved] Kelly Hares 1, Scott Miners2, Neil Scolding1, Seth Love2, Alastair Wilkins1 1Bristol Medical School: Translational Health Sciences, MS and Stem Cell Group, University of Bristol, Bristol, BS10 5NB, UK 2Bristol Medical School: Translational Health Sciences, Dementia Research Group, University of Bristol, Bristol, BS10 5NB, UK First published: 19 Feb 2019, 1:1 (https://doi.org/10.12688/amrcopenres.12861.1 Open Peer Review v1 ) Latest published: 19 Feb 2019, 1:1 ( https://doi.org/10.12688/amrcopenres.12861.1) Referee Status: Abstract Invited Referees Background: Early disturbances in axonal transport, before the onset of gross 1 2 3 neuropathology, occur in a spectrum of neurodegenerative diseases including Alzheimer’s disease.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Drp1 Overexpression Induces Desmin Disassembling and Drives Kinesin-1 Activation Promoting Mitochondrial Trafficking in Skeletal Muscle
    Cell Death & Differentiation (2020) 27:2383–2401 https://doi.org/10.1038/s41418-020-0510-7 ARTICLE Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle 1 1 2 2 2 3 Matteo Giovarelli ● Silvia Zecchini ● Emanuele Martini ● Massimiliano Garrè ● Sara Barozzi ● Michela Ripolone ● 3 1 4 1 5 Laura Napoli ● Marco Coazzoli ● Chiara Vantaggiato ● Paulina Roux-Biejat ● Davide Cervia ● 1 1 2 1,4 6 Claudia Moscheni ● Cristiana Perrotta ● Dario Parazzoli ● Emilio Clementi ● Clara De Palma Received: 1 August 2019 / Revised: 13 December 2019 / Accepted: 23 January 2020 / Published online: 10 February 2020 © The Author(s) 2020. This article is published with open access Abstract Mitochondria change distribution across cells following a variety of pathophysiological stimuli. The mechanisms presiding over this redistribution are yet undefined. In a murine model overexpressing Drp1 specifically in skeletal muscle, we find marked mitochondria repositioning in muscle fibres and we demonstrate that Drp1 is involved in this process. Drp1 binds KLC1 and enhances microtubule-dependent transport of mitochondria. Drp1-KLC1 coupling triggers the displacement of KIF5B from 1234567890();,: 1234567890();,: kinesin-1 complex increasing its binding to microtubule tracks and mitochondrial transport. High levels of Drp1 exacerbate this mechanism leading to the repositioning of mitochondria closer to nuclei. The reduction of Drp1 levels decreases kinesin-1 activation and induces the partial recovery of mitochondrial distribution. Drp1 overexpression is also associated with higher cyclin-dependent kinase-1 (Cdk-1) activation that promotes the persistent phosphorylation of desmin at Ser-31 and its disassembling. Fission inhibition has a positive effect on desmin Ser-31 phosphorylation, regardless of Cdk-1 activation, suggesting that induction of both fission and Cdk-1 are required for desmin collapse.
    [Show full text]
  • Understanding the Role of the Chromosome 15Q25.1 in COPD Through Epigenetics and Transcriptomics
    European Journal of Human Genetics (2018) 26:709–722 https://doi.org/10.1038/s41431-017-0089-8 ARTICLE Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics 1 1,2 1,3,4 5,6 5,6 Ivana Nedeljkovic ● Elena Carnero-Montoro ● Lies Lahousse ● Diana A. van der Plaat ● Kim de Jong ● 5,6 5,7 6 8 9 10 Judith M. Vonk ● Cleo C. van Diemen ● Alen Faiz ● Maarten van den Berge ● Ma’en Obeidat ● Yohan Bossé ● 11 1,12 12 1 David C. Nickle ● BIOS Consortium ● Andre G. Uitterlinden ● Joyce J. B. van Meurs ● Bruno C. H. Stricker ● 1,4,13 6,8 5,6 1 1 Guy G. Brusselle ● Dirkje S. Postma ● H. Marike Boezen ● Cornelia M. van Duijn ● Najaf Amin Received: 14 March 2017 / Revised: 6 November 2017 / Accepted: 19 December 2017 / Published online: 8 February 2018 © The Author(s) 2018. This article is published with open access Abstract Chronic obstructive pulmonary disease (COPD) is a major health burden in adults and cigarette smoking is considered the most important environmental risk factor of COPD. Chromosome 15q25.1 locus is associated with both COPD and smoking. Our study aims at understanding the mechanism underlying the association of chromosome 15q25.1 with COPD through epigenetic and transcriptional variation in a population-based setting. To assess if COPD-associated variants in 1234567890();,: 15q25.1 are methylation quantitative trait loci, epigenome-wide association analysis of four genetic variants, previously associated with COPD (P < 5 × 10−8) in the 15q25.1 locus (rs12914385:C>T-CHRNA3, rs8034191:T>C-HYKK, rs13180: C>T-IREB2 and rs8042238:C>T-IREB2), was performed in the Rotterdam study (n = 1489).
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Actin Nucleator Spire 1 Is a Regulator of Ectoplasmic Specialization in the Testis Qing Wen1,Nanli1,Xiangxiao 1,2,Wing-Yeelui3, Darren S
    Wen et al. Cell Death and Disease (2018) 9:208 DOI 10.1038/s41419-017-0201-6 Cell Death & Disease ARTICLE Open Access Actin nucleator Spire 1 is a regulator of ectoplasmic specialization in the testis Qing Wen1,NanLi1,XiangXiao 1,2,Wing-yeeLui3, Darren S. Chu1, Chris K. C. Wong4, Qingquan Lian5,RenshanGe5, Will M. Lee3, Bruno Silvestrini6 and C. Yan Cheng 1 Abstract Germ cell differentiation during the epithelial cycle of spermatogenesis is accompanied by extensive remodeling at the Sertoli cell–cell and Sertoli cell–spermatid interface to accommodate the transport of preleptotene spermatocytes and developing spermatids across the blood–testis barrier (BTB) and the adluminal compartment of the seminiferous epithelium, respectively. The unique cell junction in the testis is the actin-rich ectoplasmic specialization (ES) designated basal ES at the Sertoli cell–cell interface, and the apical ES at the Sertoli–spermatid interface. Since ES dynamics (i.e., disassembly, reassembly and stabilization) are supported by actin microfilaments, which rapidly converts between their bundled and unbundled/branched configuration to confer plasticity to the ES, it is logical to speculate that actin nucleation proteins play a crucial role to ES dynamics. Herein, we reported findings that Spire 1, an actin nucleator known to polymerize actins into long stretches of linear microfilaments in cells, is an important regulator of ES dynamics. Its knockdown by RNAi in Sertoli cells cultured in vitro was found to impede the Sertoli cell tight junction (TJ)-permeability barrier through changes in the organization of F-actin across Sertoli cell cytosol. Unexpectedly, Spire 1 knockdown also perturbed microtubule (MT) organization in Sertoli cells cultured in vitro.
    [Show full text]
  • Applying Expression Profile Similarity for Discovery of Patient-Specific
    bioRxiv preprint doi: https://doi.org/10.1101/172015; this version posted September 17, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Applying expression profile similarity for discovery of patient-specific functional mutations Guofeng Meng Partner Institute of Computational Biology, Yueyang 333, Shanghai, China email: [email protected] Abstract The progress of cancer genome sequencing projects yields unprecedented information of mutations for numerous patients. However, the complexity of mutation profiles of patients hinders the further understanding of mechanisms of oncogenesis. One basic question is how to uncover mutations with functional impacts. In this work, we introduce a computational method to predict functional somatic mutations for each of patient by integrating mutation recurrence with similarity of expression profiles of patients. With this method, the functional mutations are determined by checking the mutation enrichment among a group of patients with similar expression profiles. We applied this method to three cancer types and identified the functional mutations. Comparison of the predictions for three cancer types suggested that most of the functional mutations were cancer-type-specific with one exception to p53. By checking prediction results, we found that our method effectively filtered non-functional mutations resulting from large protein sizes. In addition, this methods can also perform functional annotation to each patient to describe their association with signalling pathways or biological processes. In breast cancer, we predicted "cell adhesion" and other mutated gene associated terms to be significantly enriched among patients.
    [Show full text]
  • Cldn19 Clic2 Clmp Cln3
    NewbornDx™ Advanced Sequencing Evaluation When time to diagnosis matters, the NewbornDx™ Advanced Sequencing Evaluation from Athena Diagnostics delivers rapid, 5- to 7-day results on a targeted 1,722-genes. A2ML1 ALAD ATM CAV1 CLDN19 CTNS DOCK7 ETFB FOXC2 GLUL HOXC13 JAK3 AAAS ALAS2 ATP1A2 CBL CLIC2 CTRC DOCK8 ETFDH FOXE1 GLYCTK HOXD13 JUP AARS2 ALDH18A1 ATP1A3 CBS CLMP CTSA DOK7 ETHE1 FOXE3 GM2A HPD KANK1 AASS ALDH1A2 ATP2B3 CC2D2A CLN3 CTSD DOLK EVC FOXF1 GMPPA HPGD K ANSL1 ABAT ALDH3A2 ATP5A1 CCDC103 CLN5 CTSK DPAGT1 EVC2 FOXG1 GMPPB HPRT1 KAT6B ABCA12 ALDH4A1 ATP5E CCDC114 CLN6 CUBN DPM1 EXOC4 FOXH1 GNA11 HPSE2 KCNA2 ABCA3 ALDH5A1 ATP6AP2 CCDC151 CLN8 CUL4B DPM2 EXOSC3 FOXI1 GNAI3 HRAS KCNB1 ABCA4 ALDH7A1 ATP6V0A2 CCDC22 CLP1 CUL7 DPM3 EXPH5 FOXL2 GNAO1 HSD17B10 KCND2 ABCB11 ALDOA ATP6V1B1 CCDC39 CLPB CXCR4 DPP6 EYA1 FOXP1 GNAS HSD17B4 KCNE1 ABCB4 ALDOB ATP7A CCDC40 CLPP CYB5R3 DPYD EZH2 FOXP2 GNE HSD3B2 KCNE2 ABCB6 ALG1 ATP8A2 CCDC65 CNNM2 CYC1 DPYS F10 FOXP3 GNMT HSD3B7 KCNH2 ABCB7 ALG11 ATP8B1 CCDC78 CNTN1 CYP11B1 DRC1 F11 FOXRED1 GNPAT HSPD1 KCNH5 ABCC2 ALG12 ATPAF2 CCDC8 CNTNAP1 CYP11B2 DSC2 F13A1 FRAS1 GNPTAB HSPG2 KCNJ10 ABCC8 ALG13 ATR CCDC88C CNTNAP2 CYP17A1 DSG1 F13B FREM1 GNPTG HUWE1 KCNJ11 ABCC9 ALG14 ATRX CCND2 COA5 CYP1B1 DSP F2 FREM2 GNS HYDIN KCNJ13 ABCD3 ALG2 AUH CCNO COG1 CYP24A1 DST F5 FRMD7 GORAB HYLS1 KCNJ2 ABCD4 ALG3 B3GALNT2 CCS COG4 CYP26C1 DSTYK F7 FTCD GP1BA IBA57 KCNJ5 ABHD5 ALG6 B3GAT3 CCT5 COG5 CYP27A1 DTNA F8 FTO GP1BB ICK KCNJ8 ACAD8 ALG8 B3GLCT CD151 COG6 CYP27B1 DUOX2 F9 FUCA1 GP6 ICOS KCNK3 ACAD9 ALG9
    [Show full text]
  • Structural Basis for Isoform-Specific Kinesin-1 Recognition of Y-Acidic
    bioRxiv preprint doi: https://doi.org/10.1101/322057; this version posted May 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Structural basis for isoform-specific kinesin-1 recognition of Y-acidic cargo adaptors Stefano Pernigo1, Magda Chegkazi1, Yan Y. Yip1, Conor Treacy1, Giulia Glorani1, Kjetil Hansen2, Argyris Politis2, Mark P. Dodding1,3,*, Roberto A. Steiner1,* 1Randall Centre of Cell and Molecular Biophysics, Faculty of Life Sciences and Medicine, King’s College London, London SE1 1UL, UK 2Department of Chemistry, King’s College London Britannia House 7 Trinity Street, London, SE1 1DB (UK) 3current address School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, University Walk, Bristol BS8 1TD *Correspondence email: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/322057; this version posted May 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The light chains (KLCs) of the heterotetrameric microtubule motor kinesin-1, that bind to cargo adaptor proteins and regulate its activity, have a capacity to recognize short peptides via their tetratricopeptide repeat domains (KLCTPR). Here, using X-ray crystallography, we show how kinesin-1 recognizes a novel class of adaptor motifs that we call ‘Y-acidic’ (tyrosine flanked by acidic residues), in a KLC-isoform specific manner. Binding specificities of Y-acidic motifs (present in JIP1 and in TorsinA) to KLC1TPR are distinct from those utilized for the recognition of W-acidic motifs found in adaptors that are KLC- isoform non-selective.
    [Show full text]
  • Involvement of the Kinesin Family Members KIF4A and KIF5C In
    Downloaded from http://jmg.bmj.com/ on March 10, 2015 - Published by group.bmj.com Cognitive and behavioural genetics ORIGINAL ARTICLE Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic Editor’s choice Scan to access more free content function Marjolein H Willemsen,1,2 Wei Ba,1,3,4 Willemijn M Wissink-Lindhout,1 Arjan P M de Brouwer,1,2 Stefan A Haas,5 Melanie Bienek,6 Hao Hu,6 Lisenka E L M Vissers,1,2 Hans van Bokhoven,1,2,3,4 Vera Kalscheuer,6 Nael Nadif Kasri,1,2,3,4 Tjitske Kleefstra1,2 For numbered affiliations see ABSTRACT genes in the development and functioning of the end of article. Introduction Kinesin superfamily (KIF) genes encode nervous system. Mice with homozygous knockout Kif1a 1b 2a 3a 3b 4a 5a 5b Correspondence to motor proteins that have fundamental roles in brain mutations in , , , , , , and Dr Nael Nadif Kasri, functioning, development, survival and plasticity by show various neurological phenotypes including Department of Cognitive regulating the transport of cargo along microtubules structural brain anomalies, decreased brain size, Neuroscience, Radboud within axons, dendrites and synapses. Mouse knockout loss of neurons, reduced rate of neuronal apoptosis university medical center, studies support these important functions in the nervous and perinatal lethality due to neurological pro- Nijmegen, The Netherlands; 4–12 Nael.NadifKasri@radboudumc. system. The role of KIF genes in intellectual disability (ID) blems. The embryonic lethality of knockout nl; has so far received limited attention, although previous mice for Kif2a, Kif3a and 3b, and Kif5b suggest Dr Tjitske Kleefstra, studies have suggested that many ID genes impinge on that these Kif genes have an important function in Department of Human synaptic function.
    [Show full text]
  • KLC1 (NM 182923) Human Tagged ORF Clone – RC220210L4 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC220210L4 KLC1 (NM_182923) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: KLC1 (NM_182923) Human Tagged ORF Clone Tag: mGFP Symbol: KLC1 Synonyms: KLC; KNS2; KNS2A Vector: pLenti-C-mGFP-P2A-Puro (PS100093) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC220210). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_182923 ORF Size: 1814 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 KLC1 (NM_182923) Human Tagged ORF Clone – RC220210L4 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_182923.2, NP_891553.2 RefSeq Size: 2548 bp RefSeq ORF: 1722 bp Locus ID: 3831 UniProt ID: Q07866 Protein Families: Druggable Genome MW: 65.1 kDa Gene Summary: Conventional kinesin is a tetrameric molecule composed of two heavy chains and two light chains, and transports various cargos along microtubules toward their plus ends.
    [Show full text]
  • Site-Specific and Common Prostate Cancer Metastasis Genes
    life Article Site-Specific and Common Prostate Cancer Metastasis Genes as Suggested by Meta-Analysis of Gene Expression Data Ivana Samaržija 1,2 1 Laboratory for Epigenomics, Division of Molecular Medicine, Ruder¯ Boškovi´cInstitute, Bijeniˇcka54, 10000 Zagreb, Croatia; [email protected] 2 Laboratory for Cell Biology and Signalling, Division of Molecular Biology, Ruder¯ Boškovi´cInstitute, Bijeniˇcka54, 10000 Zagreb, Croatia Abstract: Anticancer therapies mainly target primary tumor growth and little attention is given to the events driving metastasis formation. Metastatic prostate cancer, in comparison to localized disease, has a much worse prognosis. In the work presented here, groups of genes that are common to prostate cancer metastatic cells from bones, lymph nodes, and liver and those that are site-specific were delineated. The purpose of the study was to dissect potential markers and targets of anticancer therapies considering the common characteristics and differences in transcriptional programs of metastatic cells from different secondary sites. To that end, a meta-analysis of gene expression data of prostate cancer datasets from the GEO database was conducted. Genes with differential expression in all metastatic sites analyzed belong to the class of filaments, focal adhesion, and androgen receptor signaling. Bone metastases undergo the largest transcriptional changes that are highly enriched for the term of the chemokine signaling pathway, while lymph node metastasis show perturbation in signaling cascades. Liver metastases change the expression of genes in a way that is reminiscent of processes that take place in the target organ. Survival analysis for the common hub genes revealed Citation: Samaržija, I. Site-Specific involvements in prostate cancer prognosis and suggested potential biomarkers.
    [Show full text]